On May 15th, it was reported that Novo Nordisk is conducting trials on its weight loss drugs to explore whether they can reduce alcohol intake and treat alcoholic liver disease. The company is seekin ...

According to the latest information from Clinical Trials. gov, Novo Nordisk will launch a phase II clinical trial on May 20th to evaluate the effects of three drugs, including Smegglutide, on liver f ...